DIN 02229013 — ISOVUE 200 INJECTION 41 %
ISOVUE 200 INJECTION is a solution of Iopamidol marketed by BRACCO IMAGING CANADA. The full Iopamidol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02229013
- Brand name
- ISOVUE 200 INJECTION
- Active ingredient
- Iopamidol
- Strength
- 41 %
- Dosage form
- SOLUTION
- Route
- INTRAVASCULAR; SUBARACHNOIDAL
- Manufacturer
- BRACCO IMAGING CANADA
- Health Canada status
- MARKETED
- Drug class
- Non-ionic, low-osmolar iodinated radiographic contrast agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Iopamidol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02229021 | ISOVUE 300 INJECTION | 61 % | LIQUID | BRACCO IMAGING CANADA | MARKETED |
| 02229048 | ISOVUE 370 INJECTION | 76 % | LIQUID | BRACCO IMAGING CANADA | MARKETED |
| 02242122 | ISOVUE MULTIPACK-300 | 61 % | LIQUID | BRACCO IMAGING CANADA | MARKETED |
| 02242121 | ISOVUE MULTIPACK-370 | 76 % | LIQUID | BRACCO IMAGING CANADA | MARKETED |